DMSO-based liquid embolic agents had a reasonable safety profile in neonates, infants, and toddlers, that was comparable to published rates in older children and adults.
Joga et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: